1. Home/
  2. Compounds/
  3. navitoclax:piperlongumine (1:1 mol/mol)

navitoclax:piperlongumine (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:piperlongumine (1:1 mol/mol)
PharmacoGx navitoclax:piperlongumine (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:piperlongumine (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ADAM22 CTRPv2 pan-cancer AAC 0.23 1e-09
mRNA SNAP25 CTRPv2 pan-cancer AAC 0.23 1e-09
mRNA KMT5C CTRPv2 pan-cancer AAC 0.23 1e-09
mRNA BCL2 CTRPv2 pan-cancer AAC 0.23 1e-09
mRNA ZNF766 CTRPv2 pan-cancer AAC 0.23 1e-09
mRNA DCHS1 CTRPv2 pan-cancer AAC 0.27 1e-09
mRNA PIAS2 CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA CEP68 CTRPv2 pan-cancer AAC 0.24 1e-09
mRNA GATS CTRPv2 pan-cancer AAC 0.22 1e-09
mRNA MAST1 CTRPv2 pan-cancer AAC 0.23 2e-09
Download CSV